Trademark: 90104210
Word

Status
Dead
Status Code
606
Status Date
Monday, October 11, 2021
Serial Number
90104210
Mark Type
2000
Filing Date
Monday, August 10, 2020
Published for Opposition
Tuesday, January 12, 2021
Abandoned Date
Monday, October 11, 2021

Trademark Owner History
ATTRALUS, INC. - 1st New Owner After Publication
Aurora Bio, Inc. - Owner At Publication

Classifications
5 Diagnostic agents, preparations and substances for medical purposes; diagnostic agents for medical purposes, namely, diagnostic scanning agents for in vivo use for detection and monitoring of systemic amyloid diseases, such as transthyretin amyloidosis, Light Chain Amyloidosis and LECT2 Amyloidosis; diagnostic radiopharmaceutical preparations for clinical, medical and research use in the field of systemic amyloid disease; radioactive pharmaceutical preparations and non-radioactive reagents for producing radiopharmaceuticals for in vivo diagnostic or therapeutic use; pharmaceutical preparations for use in diagnosis and treatment of systemic amyloid disease; all of the aforesaid for human use
42 Biotechnology, medical and scientific research and development services in the field of protein therapeutics and diagnostics
The mark consists of an abstract representation of a synthetic peptide, featuring a spiral design made of connected lines and dots of various sizes.

Trademark Events
Oct 12, 2021
Abandonment Notice E-Mailed - No Use Statement Filed
Oct 11, 2021
Abandonment - No Use Statement Filed
Sep 1, 2021
Automatic Update Of Assignment Of Ownership
Mar 9, 2021
Noa E-Mailed - Sou Required From Applicant
Jan 12, 2021
Official Gazette Publication Confirmation E-Mailed
Jan 12, 2021
Published For Opposition
Dec 23, 2020
Notification Of Notice Of Publication E-Mailed
Dec 3, 2020
Approved For Pub - Principal Register
Dec 3, 2020
Assigned To Examiner
Sep 11, 2020
Notice Of Design Search Code E-Mailed
Sep 10, 2020
New Application Office Supplied Data Entered In Tram
Aug 13, 2020
New Application Entered In Tram

Trademark Alertz updated from USPTO on 2030-01-24